We found strong evidence for a protective effect of HLA-DRB5 expression on colon-specific CRC risk in memory T cells (TCM) 5 d post-activation (OR = 0.94, CI = 0.92–0.96). The gene discussed is HLA-DRB5; the disease is colorectal carcinoma.